Multiple hyperlinks to rcsb

Your request to link to rcsb for Androgen receptor

1E3G: human androgen receptor ligand binding in complex with the ligand metribolone (r1881) (10.1074/JBC.M004571200 )
1GS4: structural basis for the glucocorticoid response in a mutant human androgen receptor (arccr) derived from an androgen-independent prostate cancer (10.1021/JM011072J )
1I37: crystal structure of the rat androgen receptor ligand binding domain complex with dihydrotestosterone (10.1073/PNAS.081565498 )
1I38: crystal structure of the rat androgen receptor ligand binding domain t877a mutant complex with dihydrotestosterone (10.1073/PNAS.081565498 )
1R4I: crystal structure of androgen receptor dna-binding domain bound to a direct repeat response element (10.1073/PNAS.0401123101 )
1T5Z: crystal structure of the androgen receptor ligand binding domain (lbd) with dht and a peptide derived from its physiological coactivator ara70 (10.1074/JBC.M407046200 )
1T63: crystal structure of the androgen receptor ligand binding domain with dht and a peptide derived from its physiological coactivator grip1 nr box3 (10.1074/JBC.M407046200 )
1T65: crystal structure of the androgen receptor ligand binding domain with dht and a peptide derived form its physiological coactivator grip1 nr box 2 bound in a non-helical conformation (10.1074/JBC.M407046200 )
1T73: crystal structure of the androgen receptor ligand binding domain in complex with a fxxff motif (10.1371/JOURNAL.PBIO.0020274 )
1T74: crystal structure of the androgen receptor ligand binding domain in complex with a wxxlf motif (10.1371/JOURNAL.PBIO.0020274 )
1T76: crystal structure of the androgen receptor ligand binding domain in complex with a wxxvw motif (10.1371/JOURNAL.PBIO.0020274 )
1T79: crystal structure of the androgen receptor ligand binding domain in complex with a fxxlw motif (10.1371/JOURNAL.PBIO.0020274 )
1T7F: crystal structure of the androgen receptor ligand binding domain in complex with a lxxll motif (10.1371/JOURNAL.PBIO.0020274 )
1T7M: crystal structure of the androgen receptor ligand binding domain in complex with a fxxyf motif (10.1371/JOURNAL.PBIO.0020274 )
1T7R: crystal structure of the androgen receptor ligand binding domain in complex with a fxxlf motif (10.1371/JOURNAL.PBIO.0020274 )
1T7T: crystal structure of the androgen receptor ligand binding domain in complex with 5-alpha dihydrotestosterone (10.1371/JOURNAL.PBIO.0020274 )
1XJ7: complex androgen receptor lbd and rac3 peptide (10.1074/JBC.M407046200 )
1XNN: crystal structure of the rat androgen receptor ligand binding domain t877a mutant complex with (3a-alpha-,4- alpha 7-alpha-,7a-alpha-)-3a,4,7,7a-tetrahydro-2-(4-nitro- 1-naphthalenyl)-4,7-ethano-1h-isoindole-1,3(2h)-dione. (10.1016/J.BMCL.2004.10.085 )
1XOW: crystal structure of the human androgen receptor ligand binding domain bound with an androgen receptor nh2-terminal peptide, ar20-30, and r1881 (10.1016/J.MOLCEL.2004.09.036 )
1XQ3: crystal structure of the human androgen receptor ligand binding domain bound with r1881 (10.1016/J.MOLCEL.2004.09.036 )
1Z95: crystal structure of the androgen receptor ligand-binding domain w741l mutant complex with r-bicalutamide (10.1073/PNAS.0500381102 )
2AM9: crystal structure of human androgen receptor ligand binding domain in complex with testosterone (10.1110/PS.051905906 )
2AMA: crystal structure of human androgen receptor ligand binding domain in complex with dihydrotestosterone (10.1110/PS.051905906 )
2AMB: crystal structure of human androgen receptor ligand binding domain in complex with tetrahydrogestrinone (10.1110/PS.051905906 )
2AO6: crystal structure of the human androgen receptor ligand binding domain bound with tif2(iii) 740-753 peptide and r1881 (10.1016/J.MOLCEL.2004.09.036 )
2AX6: crystal structure of the androgen receptor ligand binding domain t877a mutant in complex with hydroxyflutamide (10.1074/JBC.M507464200 )
2AX7: crystal structure of the androgen receptor ligand binding domain t877a mutant in complex with s-1 (10.1074/JBC.M507464200 )
2AX8: crystal structure of the androgen receptor ligand binding domain w741l mutant in complex with s-1 (10.1074/JBC.M507464200 )
2AX9: crystal structure of the androgen receptor ligand binding domain in complex with r-3 (10.1074/JBC.M507464200 )
2AXA: crystal structure of the androgen receptor ligand binding domain in complex with s-1 (10.1074/JBC.M507464200 )
2HVC: the crystal structure of ligand-binding domain (lbd) of human androgen receptor in complex with a selective modulator lgd2226 (10.1107/S1744309106039340 )
2IHQ: crystal structure of the rat androgen receptor ligand binding domian complex with an n-aryl- hydroxybicyclohydantoin (10.1021/JM061101W )
2NW4: crystal structure of the rat androgen receptor ligand binding domain complex with bms-564929 (10.1210/EN.2006-0843 )
2OZ7: crystal structure of the human androgen receptor t877a mutant ligand- binding domain with cyproterone acetate (10.1074/JBC.M611711200 )
2PIO: androgen receptor lbd with small molecule (10.1073/PNAS.0708036104 )
2PIP: androgen receptor lbd with small molecule (10.1073/PNAS.0708036104 )
2PIQ: androgen receptor lbd with small molecule (10.1073/PNAS.0708036104 )
2PIR: androgen receptor lbd with small molecule (10.1073/PNAS.0708036104 )
2PIT: androgen receptor lbd with small molecule (10.1073/PNAS.0708036104 )
2PIU: androgen receptor lbd with small molecule (10.1073/PNAS.0708036104 )
2PIV: androgen receptor with small molecule (10.1073/PNAS.0708036104 )
2PIW: androgen receptor with small molecule (10.1073/PNAS.0708036104 )
2PIX: ar lbd with small molecule (10.1073/PNAS.0708036104 )
2PKL: androgen receptor lbd with small molecule (10.1073/PNAS.0708036104 )
2PNU: crystal structure of human androgen receptor ligand-binding domain in complex with em-5744 (10.1074/JBC.M705524200 )
2Q7I: the wild type androgen receptor ligand binding domain bound with testosterone and an ar 20-30 peptide (10.1074/JBC.M703268200 )
2Q7J: the wild type androgen receptor ligand binding domain bound with testosterone and a tif2 box 3 coactivator peptide 740-753 (10.1074/JBC.M703268200 )
2Q7K: the androgen receptor prostate cancer mutant h874y ligand binding domain bound with testosterone and an ar 20-30 peptide (10.1074/JBC.M703268200 )
2Q7L: the androgen receptor prostate cancer mutant h874y ligand binding domain bound with testosterone and a tif2 box3 coactivator peptide 740-753 (10.1074/JBC.M703268200 )
2QPY: ar lbd with small molecule (10.1073/PNAS.0708036104 )
2YHD: human androgen receptor in complex with af2 small molecule inhibitor (10.1021/JM200532B )
2YLO: targeting the binding function 3 site of the androgen receptor through in silico molecular modeling (10.1021/JM201098N )
2YLP: targeting the binding function 3 site of the androgen receptor through in silico molecular modeling (10.1021/JM201098N )
2YLQ: targeting the binding function 3 site of the androgen receptor through in silico molecular modeling (10.1021/JM201098N )
2Z4J: crystal structure of ar lbd with shp peptide nr box 2 (10.1107/S0907444907045702 )
3B5R: crystal structure of the androgen receptor ligand binding domain in complex with sarm c-31 (10.1016/J.BMCL.2008.09.002 )
3B65: crystal structure of the androgen receptor ligand binding domain in complex with sarm s-24 (10.1016/J.BMCL.2008.09.002 )
3B66: crystal structure of the androgen receptor ligand binding domain in complex with sarm s-21 (10.1016/J.BMCL.2008.09.002 )
3B67: crystal structure of the androgen receptor ligand binding domain in complex with sarm c-23 (10.1016/J.BMCL.2008.09.002 )
3B68: crystal structure of the androgen receptor ligand binding domain in complex with sarm s-4 (10.1016/J.BMCL.2008.09.002 )
3G0W: crystal structure of the rat androgen receptor ligand binding domain complex with an n-aryl-oxazolidin 2-imine inhibitor (10.1021/JM801583J )
3L3X: crystal structure of dht-bound androgen receptor in complex with the first motif of steroid receptor coactivator 3 (10.1074/JBC.M109.085779 )
3L3Z: crystal structure of dht-bound androgen receptor in complex with the third motif of steroid receptor coactivator 3 (10.1074/JBC.M109.085779 )
3RLJ: crystal structure of the androgen receptor ligand binding domain in complex with sarm s-22 (10.1021/JM2000097 )
3RLL: crystal structure of the t877a androgen receptor ligand binding domain in complex with (s)-n-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4- cyanonaphthalen-1-yloxy)-2-hydroxy-2-methylpropanamide (10.1021/JM2000097 )
3V49: structure of ar lbd with activator peptide and sarm inhibitor 1 (10.1021/JM300249M )
3V4A: structure of ar lbd with activator peptide and sarm inhibitor 2 (10.1021/JM300249M )
3ZQT: targeting the binding function 3 site of the androgen receptor through in silico molecular modeling (10.1021/JM201098N )
4HLW: targeting the binding function 3 (bf3) site of the human androgen receptor through virtual screening. 2. development of 2-((2- phenoxyethyl) thio)-1h-benzoimidazole derivatives. (10.1021/JM3015712 )
4K7A: crystal structure of the androgen receptor ligand binding domain in complex with minoxidil
4OEA: crystal structure of ar-lbd (10.1016/J.MOLONC.2014.06.009 )
4OED: crystal structure of ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OEY: crystal structure of ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OEZ: crystal structure of ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OFR: crystal structure of ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OFU: crystal structure of ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OGH: crystal structure of t877a-ar-lbd (10.1016/J.MOLONC.2014.06.009 )
4OH5: crystal structure of t877a-ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OH6: crystal structure of t877a-ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OHA: crystal structure of t877a-ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OIL: crystal structure of t877a-ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OIU: crystal structure of t877a-ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OJ9: crystal structure of t877a-ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OJB: crystal structure of w741l-ar-lbd (10.1016/J.MOLONC.2014.06.009 )
4OK1: crystal structure of w741l-ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OKB: crystal structure of w741l-ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OKT: crystal structure of w741l-ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OKW: crystal structure of w741l-ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OKX: crystal structure of w741l-ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4OLM: crystal structure of w741l-ar-lbd bound with co-regulator peptide (10.1016/J.MOLONC.2014.06.009 )
4QL8: crystal structure of androgen receptor in complex with the ligand (10.1021/JM5009049 )
5CJ6: crystal structure of a selective androgen receptor modulator bound to the ligand binding domain of the human androgen receptor (10.1021/ACS.JMEDCHEM.5B01168 )
5JJM: crystal structure of homodimeric androgen receptor ligand-binding domain bound to dht and lxxll peptide (10.1038/NCOMMS14388 )
5T8E: synthesis and biological evaluation of novel selective androgen receptor modulators (sarms). part ii: optimization of 4-(pyrrolidin- 1-yl)benzonitrile derivatives (10.1016/J.BMCL.2017.03.038 )
5T8J: synthesis and biological evaluation of novel selective androgen receptor modulators (sarms). part ii: optimization of 4-(pyrrolidin- 1-yl)benzonitrile derivatives (10.1016/J.BMCL.2017.03.038 )
5V8Q: synthesis and biological evaluation of novel selective androgen receptor modulators (sarms): part iii (10.1016/J.BMC.2017.04.018 )
5VO4: crystal structure of the androgen receptor ligand binding domain in complex with 5-(2-fluoro-4-hydroxyphenyl)-1-methyl-1h-pyrrole-2- carbonitrile (10.1021/ACS.JMEDCHEM.7B00373 )